Diagnostic value of B-RAFV600E in difficult-to-diagnose thyroid nodules using fine-needle aspiration: Systematic review and meta-analysis

Diagnostic Cytopathology

Volumn 42, Issue 1, 2014, Pages 94-101

  Jia, Yongsheng ^a   Yu, Yang ^a   Li, Xiaolong ^b   Wei, Songfeng ^a   Zheng, Xiangqian ^b   Yang, Xiaoyong ^a   Zhao, Jing ^a   Xia, Tingting ^a   Gao, Ming ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

BRAFV600E; fine needle aspiration; thyroid nodule

Indexed keywords

B RAF KINASE;

AREA UNDER THE CURVE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; THYROID NODULE;

BRAFV600E; FINE-NEEDLE ASPIRATION; THYROID NODULE;

BIOPSY, FINE-NEEDLE; HUMANS; MUTATION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS B-RAF; SENSITIVITY AND SPECIFICITY; THYROID NODULE;

EID: 84891445627     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23044     Document Type: Review

References (50)

1. Hegedüs L,. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351: 1764-1771.
2. Gharib H, Papini E,. Thyroid nodules: Clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007; 36: 707-735.
3. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
4. Goellner JR, Gharib H, Grant CS, Johnson DA,. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 1987; 31: 587-590.
5. Gharib H, Goellner JR,. Fine-needle aspiration biopsy of the thyroid: An appraisal. Ann Intern Med 1993; 118: 282-289.
6. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ,. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998; 8: 283-289.
7. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A,. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy ofthyroid nodules. Thyroid 1998; 8: 15-21.
8. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM,. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroidcancer. Thyroid 2009; 19: 1167-1214.
9. Gharib H, Goellner JR,. Fine-needle aspiration biopsy of the thyroid: An appraisal. Ann Intern Med 1993; 118: 282-289.
10. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA,. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954.
11. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D,. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003; 95: 625-627.
12. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA,. High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003; 63: 1454-1457.
13. Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R,. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: Data from a multicentric Italian study and review of the literature. Endocr Relat Cancer 2006; 13: 455-464.
14. Garnett MJ, Marais R,. Guilty as charged: B-RAF is a human oncogene. Cancer Cell 2004; 6: 313-319.
15. Xing, M,. BRAF mutation in thyroid cancer. Endocrine Related Cancer 2005; 12: 245-262.
16. Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park do J, Lee HS, Cho BY, Lee ES, Kim SW,. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol(Oxf) 2006; 65: 660-666.
17. Nikiforov YE, Nikiforova MN,. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011; 7: 569-580.
18. Marchetti I, Iervasi G, Mazzanti CM, et al. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: An easy tool to improve the preoperative diagnosis. Thyroid 2012; 22: 292-298.
19. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J,. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
20. The Cochrane Collaboration: Review Manager (RevMan). Version 5.0. Copenhagen, Denmark: The Nordic Cochrane Centre; 2008.
21. Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH,. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: A potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 2004; 10: 2761-2765.
22. Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C,. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid 2007; 17: 1109-1115.
23. Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS,. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 2008; 17: 118-125.
24. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G,. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Thyroid 2009; 19: 837-842.
25. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN,. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009; 94: 2092-2098.
26. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F,. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves thediagnostic accuracy of cytology. J Clin Endocrinol Metab 2010; 95: 1365-1369.
27. Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH,. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: A potential guide for selection of samples for molecular analysis. Thyroid. 2010; 20: 273-279.
28. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E,. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 2010; 34: 2589-2594.
29. Kwak JY, Kim EK, Kim JK, Han JH, Hong SW, Park TS, Choi JR,. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area. Head Neck 2010; 32: 490-498.
30. Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH,. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: A large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 2010; 95: 3693-3700.
31. Lee EJ, Song KH, Kim DL, Jang YM, Hwang TS, Kim SK,. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroidnodules. Clin Endocrinol (Oxf) 2011; 75: 844-850.
32. Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C,. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytol 2011; 55: 570-575.
33. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN,. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminatethyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011; 96: 3390-3397.
34. Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC,. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: A prospective study. Thyroid 2011; 21: 1-7.
35. V600E mutation-prevalent area. J Clin Endocrinol Metab 2012; 97: 2299-2306.
36. Kang G, Cho EY, Shin JH, Chung JH, Kim JW, Oh YL,. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule. Cancer Cytopathol 2012; 120: 44-51.
37. Nikiforov YE, Steward DL, Robinson-Smith TM,. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009; 94: 2092-2098.
38. Kim K, Kang D, Kim S, Seong IO, Kang DY,. Mutations of BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 2004; 45: 818-821.
39. Ezzat S, Sarti DA, Cain DR, Braunstein GD,. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154: 1838-1840.
40. Xing M,. BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762.
41. Lee JH, Lee ES, Kim YS,. Clinicopathologic significance of BRAFV600E mutation in papillary carcinomas of the thyroid: A meta-analysis. Cancer 2007; 110: 38-46.
42. Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A,. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 2007; 246: 466-470, discussion 470-471.
43. Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F,. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study. J Clin Endocrinol Metab 2008; 93: 3943-3949.
44. Shibru D, Chung KW, Kebebew E,. Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol 2008; 20: 13-18.
45. Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, Zeiger MA, Kebebew E,. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol 2011; 18: 3443-3452.
46. Mazeh H,. MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules. Oncologist 2012 Jun 15. [Epub ahead of print].
47. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, Livolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR,. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012: 367: 705-715.
48. Chun JY, Kim KJ, Hwang IT, Kim YJ, Lee DH, Lee IK, Kim JK,. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res 2007; 35: 6.
49. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW,. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005; 90: 6373-6379.
50. Mazzaferri EL,. Managing small thyroid cancers. JAMA 2006; 295: 2179-2182.